📊 CNS Key Takeaways
Is Cohen & Steers, Inc.. (CNS) a Good Investment?
Cohen & Steers exhibits strong operating margins (34.4%) and revenue growth (+7.5% YoY), but faces a critical cash flow crisis with negative operating cash flow of -$51.4M and free cash flow of -$57.3M, indicating the company cannot convert reported profits into cash. Despite a fortified balance sheet with no long-term debt, the deteriorating net income (-2.7% YoY) combined with severe cash burn raises concerns about operational sustainability and earnings quality.
Cohen & Steers shows strong core fundamentals through high operating and net margins, solid returns on equity and assets, and a debt-free balance sheet with meaningful cash reserves. However, the latest period raises a material quality-of-earnings concern because strong reported profitability did not convert into cash, with operating cash flow and free cash flow both sharply negative. Revenue growth remains positive, but the combination of flat EPS and weaker net income suggests fundamentals are solid rather than clearly accelerating.
Why Buy Cohen & Steers, Inc.. Stock? CNS Key Strengths
- Exceptional operating margin of 34.4% demonstrates strong cost control
- Revenue growth of 7.5% YoY shows market demand
- Fortress balance sheet with zero long-term debt and D/E ratio of 0.0x provides financial flexibility
- High profitability with 32.0% operating margin and 27.6% net margin
- Strong capital efficiency, with ROE of 27.3% and ROA of 17.5%
- Healthy balance sheet supported by $145.45M in cash and no meaningful debt leverage
CNS Stock Risks: Cohen & Steers, Inc.. Investment Risks
- Severe negative operating cash flow (-$51.4M) indicates inability to convert profits to cash—fundamentally unsustainable
- Net income declining 2.7% YoY despite 7.5% revenue growth signals deteriorating operational efficiency and margin compression
- Low returns on equity (7.5%) and assets (5.0%) suggest inefficient capital deployment and weak earning power
- Operating cash flow of -$120.44M and free cash flow of -$126.42M indicate weak cash conversion
- Net income declined 2.7% year over year despite revenue growth, implying margin or expense pressure
- Asset-management fundamentals can be sensitive to fee compression, market levels, and investor flows
Key Metrics to Watch
- Operating cash flow trend and reconciliation with net income
- Working capital changes and receivables growth
- Net margin progression and cost structure management
- Operating cash flow and free cash flow normalization
- Net income and EPS growth relative to revenue growth
Cohen & Steers, Inc.. (CNS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CNS Profit Margin, ROE & Profitability Analysis
CNS vs Market Sector: How Cohen & Steers, Inc.. Compares
How Cohen & Steers, Inc.. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cohen & Steers, Inc.. Stock Overvalued? CNS Valuation Analysis 2026
Based on fundamental analysis, Cohen & Steers, Inc.. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cohen & Steers, Inc.. Balance Sheet: CNS Debt, Cash & Liquidity
CNS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cohen & Steers, Inc..'s revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $2.60 reflects profitable operations.
CNS Revenue Growth, EPS Growth & YoY Performance
CNS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $134.5M | $39.8M | $0.77 |
| Q3 2025 | $133.2M | $39.7M | $0.77 |
| Q2 2025 | $121.7M | $31.8M | $0.63 |
| Q1 2025 | $122.7M | $34.0M | $0.68 |
| Q3 2024 | $123.7M | $32.1M | $0.65 |
| Q2 2024 | $120.6M | $31.8M | $0.63 |
| Q3 2023 | $123.7M | $32.1M | $0.65 |
| Q2 2023 | $120.6M | $31.8M | $0.64 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cohen & Steers, Inc.. Dividends, Buybacks & Capital Allocation
CNS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cohen & Steers, Inc.. (CIK: 0001284812)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CNS
What is the AI rating for CNS?
Cohen & Steers, Inc.. (CNS) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 76% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CNS's key strengths?
Claude: Exceptional operating margin of 34.4% demonstrates strong cost control. Revenue growth of 7.5% YoY shows market demand. ChatGPT: High profitability with 32.0% operating margin and 27.6% net margin. Strong capital efficiency, with ROE of 27.3% and ROA of 17.5%.
What are the risks of investing in CNS?
Claude: Severe negative operating cash flow (-$51.4M) indicates inability to convert profits to cash—fundamentally unsustainable. Net income declining 2.7% YoY despite 7.5% revenue growth signals deteriorating operational efficiency and margin compression. ChatGPT: Operating cash flow of -$120.44M and free cash flow of -$126.42M indicate weak cash conversion. Net income declined 2.7% year over year despite revenue growth, implying margin or expense pressure.
What is CNS's revenue and growth?
Cohen & Steers, Inc.. reported revenue of $145.6M.
Does CNS pay dividends?
Cohen & Steers, Inc.. pays dividends, with $34.5M distributed to shareholders in the trailing twelve months.
Where can I find CNS SEC filings?
Official SEC filings for Cohen & Steers, Inc.. (CIK: 0001284812) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CNS's EPS?
Cohen & Steers, Inc.. has a diluted EPS of $0.82.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CNS a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Cohen & Steers, Inc.. has a SELL rating with 76% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CNS stock overvalued or undervalued?
Valuation metrics for CNS: ROE of 7.5% (sector avg: 15%), net margin of 29.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy CNS stock in 2026?
Our dual AI analysis gives Cohen & Steers, Inc.. a combined SELL rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is CNS's free cash flow?
Cohen & Steers, Inc..'s operating cash flow is $-51.4M, with capital expenditures of $6.0M. FCF margin is -39.4%.
How does CNS compare to other Market stocks?
Vs Default sector averages: Net margin 29.1% (avg: 12%), ROE 7.5% (avg: 15%), current ratio N/A (avg: 1.8).